A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)

- Wigg, Alan, Tibballs, Jonathan, Haworth, Annette, Hardcastle, Nicholas, Loo, Kee Fong, Tang, Colin, Lee, Yoo Young, Chu, Julie, De Abreu Lourenco, Richard, Koukourou, Adam, De Boo, Diederick, McLean, Kate, Woodman, Richard, Buck, Jackie, Sawhney, R, Nicoll, A, Dev, A, Wood, M, Braund, A, Weltman, M, Khor, R, Levy, M, Wang, T, Stuart, Katherine, Potter, M, Haridy, J, Raj, A, Duncan, O, Zekry, A, Collier, N, O’Beirne, J, Holliday, C, Trada, Y, Tronidjaja, J, Le, Hien, George, J, Pryor, D, Roberts, Stuart K., Olynyk, John K., Strasser, Simone I., Wallace, Michael, Martin, Jarad

Clinical target volume delineation quality assurance for MRI-guided prostate radiotherapy using deep learning with uncertainty estimation

- Min, Hang, Dowling, Jason, Chlap, Phillip, de Leon, Jeremiah, Berry, Megan, Pryor, David, Greer, Peter, Vinod, Shalini K., Holloway, Lois, Jameson, Michael G., Cloak, Kirrily, Faustino, Joselle, Sidhom, Mark, Martin, Jarad, Cardoso, Michael, Ebert, Martin A., Haworth, Annette

A statistical, voxelised model of prostate cancer for biologically optimised radiotherapy

- Finnegan, Robert N., Reynolds, Hayley M., Ebert, Martin A., Sun, Yu, Holloway, Lois, Sykes, Jonathan R., Dowling, Jason, Mitchell, Catherine, Williams, Scott G., Murphy, Declan G., Haworth, Annette

Automatic radiotherapy delineation quality assurance on prostate MRI with deep learning in a multicentre clinical trial

- Min, Hang, Dowling, Jason, De Leon, Jeremiah, Berry, Megan, Pryor, David, Greer, Peter, Vinod, Shalini K., Holloway, Lois, Jameson, Michael G., Cloak, Kirrily, Faustino, Joselle, Sidhom, Mark, Martin, Jarad, Ebert, Martin A., Haworth, Annette, Chlap, Phillip

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

- Kneebone, Andrew, Fraser-Browne, Carol, Duchesne, Gillian M., Fisher, Richard, Frydenberg, Mark, Herschtal, Alan, Williams, Scott G., Brown, Chris, Delprado, Waeick, Haworth, Annette, Joseph, David J., Martin, Jarad M., Matthews, John H. L., Millar, Jeremy L., Sidhom, Milllar, Spry, Nigel, Tang, Colin I., Turner, Sandra, Wiltshire, Kirsty L., Woo, Henry H., Davis, Ian D., Lim, Tee S., Pearse, Maria

Increased dose to organs in urinary tract associates with measures of genitourinary toxicity in pooled voxel-based analysis of 3 randomized phase III trials

- Marcello, Marco, Denham, James W., Kennedy, Angel, Haworth, Annette, Steigler, Allison, Greer, Peter B., Holloway, Lois C., Dowling, Jason A., Jameson, Michael G., Roach, Dale, Joseph, David J., Gulliford, Sarah L., Dearnaley, David P., Sydes, Matthew R., Hall, Emma, Ebert, Martin A.

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

- Joseph, David, Denham, James W., Turner, Sandra, Kenny, Lizbeth, Christie, David, Tai, Keen-Hun, Gogna, NirdoshK, Kearvell, Rachel, Murray, Judy, Ebert, Martin A., Haworth, Annette, Delahunt, Brett, Steigler, Allison, Oldmeadow, Christopher, Attia, John, Lamb, David S., Spry, Nigel A., Stanley, John, Shannon, Tom, Duchesne, Gillian, Atkinson, Chris, Matthews, John H. L.

Reduced dose posterior to prostate correlates with increased PSA progression in voxel-based analysis of 3 randomized phase 3 trials

- Marcello, Marco, Denham, James W., Joseph, David J., Gulliford, Sarah L., Dearnaley, David P., Sydes, Matthew R., Hall, Emma, Ebert, Martin A., Kennedy, Angel, Haworth, Annette, Steigler, Allison, Greer, Peter B., Holloway, Lois C., Dowling, Jason A., Jameson, Michael G., Roach, Dale

Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials

- Marcello, Marco, Denham, James W., Kennedy, Angel, Haworth, Annette, Steigler, Allison, Greer, Peter B., Holloway, Lois C., Dowling, Jason A., Jameson, Michael G., Roach, Dale, Joseph, David J., Gulliford, Sarah L., Dearnaley, David P., Sydes, Mathew R., Hall, Emma, Ebert, Martin A.

Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trial

- Marcello, Marco, Ebert, Martin A., Haworth, Annette, Steigler, Allison, Kennedy, Angel, Bulsara, Max, Kearvell, Rachel, Joseph, David J., Denham, James W.

Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial

- Marcello, Marco, Ebert, Martin, Haworth, Annette, Steigler, Allison, Kennedy, Angel, Joseph, David, Denham, James

A virtual dosimetry audit - towards transferability of gamma index analysis between clinical trial QA groups

- Hussein, Mohammad, Clementel, Enrico, Nakamura, Mitsuhiro, Hurkmans, Coen, Clark, Catherine H., Global Quality Assurance of Radiation Therapy Clinical Trial Harmonisation Group,, Eaton, David J., Greer, Peter B., Haworth, Annette, Ishikura, Satoshi, Kry, Stephen F., Lehmann, Joerg, Lye, Jessica, Monti, Angelo F.

Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial

- Yahya, Noorazul, Ebert, Martin A., Bulsara, Max, Haworth, Annette, Kennedy, Angel, Joseph, David J., Denham, Jim W.

Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: analysis of data from the radar prostate radiation therapy trial

- Ebert, Martin A., Foo, Kerwyn, Haworth, Annette, Gulliford, Sarah L., Kennedy, Angel, Joseph, David J., Denham, James W.

Optimizing radiation therapy quality assurance in clinical trials: a TROG 08.03 RAVES substudy

- Trada, Yuvnik, Kneebone, Andrew, Paneghel, Andrea, Pearse, Maria, Sidhom, Mark, Tang, Colin, Wiltshire, Kirsty, Haworth, Annette, Fraser-Browne, Carol, Martin, Jarad

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

- Denham, James W., Steigler, Allison, Tai, Keen-Hun, Gogna, Nirdosh Kumar, Gill, Suki, Tan, Hendrick, Kearvell, Rachel, Murray, Judy, Ebert, Martin, Haworth, Annette, Kennedy, Angel, Delahunt, Brett, Joseph, David, Oldmeadow, Christopher, Holliday, Elizabeth G., Attia, John, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Atkinson, Chris, Matthews, John, Turner, Sandra, Kenny, Lizbeth

Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: are the results reflected in observed toxicity rates?

- Ebert, Martin A., Bulsara, Max, Haworth, Annette, Kearvell, Rachel, Richardson, Sharon, Kennedy, Angel, Spry, Nigel A., Bydder, Sean A., Joseph, David J., Denham, James W.

Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial

- Yahya, Noorazrul, Ebert, Martin A., Denham, Jim W., Bulsara, Max, Haworth, Annette, Kearvell, Rachel, Foo, Kerwyn, Kennedy, Angel, Richardson, Sharon, Krawiec, Michele, Joseph, David J.

Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial

- Kearvell, Rachel, Haworth, Annette, Denham, James W., Ebert, Martin A., Murray, Judy, Hooton, Ben, Richardson, Sharon, Joseph, David J., Lamb, David, Spry, Nigel A., Duchesne, Gillian

Assuring high quality treatment delivery in clinical trials: results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study

- Haworth, Annette, Kearvell, Rachel, Greer, Peter B., Hooton, Ben, Denham, James W., Lamb, David, Duchesne, Gillian, Murray, Judy, Joseph, David